Kerimov, Nurlan https://orcid.org/0000-0001-7660-3148
Hayhurst, James D.
Peikova, Kateryna
Manning, Jonathan R.
Walter, Peter
Kolberg, Liis https://orcid.org/0000-0002-0118-7562
Samoviča, Marija
Sakthivel, Manoj Pandian
Kuzmin, Ivan https://orcid.org/0000-0001-9138-9901
Trevanion, Stephen J.
Burdett, Tony
Jupp, Simon https://orcid.org/0000-0002-0643-3144
Parkinson, Helen
Papatheodorou, Irene https://orcid.org/0000-0001-7270-5470
Yates, Andrew D.
Zerbino, Daniel R. https://orcid.org/0000-0001-5350-3056
Alasoo, Kaur https://orcid.org/0000-0002-1761-8881
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (825775)
Eesti Teadusagentuur (MOBJD67, PSG415, IUT34-4, PSG415, PSG415, PSG59)
Open Targets
European Molecular Biology Laboratory
Wellcome Trust (108749/Z/15/Z, 108749/Z/15/Z)
European Bioinformatics Institute
EC | European Regional Development Fund (2014-2020.4.01.16-0271)
Article History
Received: 8 January 2021
Accepted: 26 July 2021
First Online: 6 September 2021
Competing interests
: Since April 2021, D.R.Z. has been a full-time employee of Mosaic Therapeutics, UK. The other authors declare no competing interests.